PTPI
Petros Pharmaceuticals, Inc.
Key Financials
Revenue
$5.1M
↓ 12.2%
Net Income
$-14318790
↓ 75.4%
Operating Income
$-17679650
↓ 29.8%
EPS (Diluted)
$-3.34
↑ 47.4%
Gross Profit
$3.9M
↓ 7.0%
Total Assets
$10.6M
↓ 68.5%
Cash & Equivalents
$3.7M
↓ 72.1%
Shareholders' Equity
$-7467578.00
↓ 161.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PTPI |
| Company Name | Petros Pharmaceuticals, Inc. |
| CIK | 1815903 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 973-242-0005 |